Ophthalmic Lasers Market - Global Outlook & Forecast 2024-2029

List of Tables

The global ophthalmic lasers market is expected to grow at a CAGR of 5.56% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Expanding Ophthalmic Lasers Application in Glaucoma Treatment

The advent of advanced technologies in the medical field has significantly revolutionized treatment methods, and ophthalmology is no exception. One notable area of advancement is the application of ophthalmic lasers in treating glaucoma, which has opened up new avenues and opportunities in the market. Glaucoma is a group of eye conditions that damage the optic nerve, often due to abnormally high intraocular pressure (IOP). Ophthalmic lasers have become a cornerstone in managing glaucoma, offering a minimally invasive alternative to traditional surgical methods. The primary types of laser treatments used for glaucoma include Argon Laser Trabeculoplasty (ALT), Selective Laser Trabeculoplasty (SLT), Laser Peripheral Iridotomy (LPI), and Cyclophotocoagulation.

Advancements in Laser Technology for Ophthalmic Surgery

Advancements in laser technology for ophthalmic surgery are revolutionizing eye care, offering new opportunities for the global ophthalmic lasers market. Enhanced precision, broadened applications, and the integration of smart systems are driving demand and fostering innovation. As the prevalence of eye diseases continues to rise and emerging markets adopt these advanced technologies, the ophthalmic laser market is set to experience significant growth. This dynamic landscape promises better vision health for millions and presents lucrative opportunities for industry stakeholders.

Continuous Product Approvals

The continuous product approvals and new product launches are pivotal drivers of growth and innovation in the global ophthalmic lasers market. These advancements expand treatment options for eye care professionals and enhance patient satisfaction and clinical outcomes. As technology evolves and regulatory frameworks adapt to novel innovations, the ophthalmic laser market is poised for sustained expansion. For instance, the approval of the Zeiss VisuMax Femtosecond Laser for Small Incision Lenticule Extraction (SMILE) has been a game-changer in refractive surgery. SMILE offers a minimally invasive alternative to LASIK, enabling surgeons to reshape the cornea with high precision and minimal disruption to surrounding tissue. Its approval has expanded treatment options for patients seeking vision correction, boosting market growth.

Rising Prevalence of Eye Disorders

The rising prevalence of eye disorders is a significant global health concern driving the demand for advanced ophthalmic treatments, particularly laser-based therapies. Ophthalmic lasers offer precise, effective, and minimally invasive solutions for various eye conditions, significantly improving patient outcomes. As the global population ages and the incidence of chronic diseases like diabetes increases, the need for ophthalmic lasers is expected to continue growing. Consequently, the global market for these devices is poised for substantial expansion, underscoring the critical role of innovation and technology in addressing the challenges of vision impairment and blindness worldwide.

Growing Preference for Minimally Invasive Ophthalmic Procedures

The global ophthalmic lasers market is experiencing robust growth, fueled by the rising preference for minimally invasive ophthalmic procedures. This is driven by technological advancements, an aging population, the rising incidence of eye disorders, and increased patient awareness. As technology continues to evolve and more patients and healthcare providers recognize the benefits of minimally invasive procedures, the demand for ophthalmic lasers is expected to sustain its upward trajectory. This evolution not only promises improved patient outcomes but also signifies a transformative shift in the field of ophthalmology, paving the way for more precise, efficient, and patient-friendly eye care solutions.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

The global ophthalmic lasers market by product type is segmented into femtosecond, excimer, Nd: YAG, diode, and others. Femtosecond lasers are primarily used in cataract surgery to create precise cornea and lens capsule incisions. They enhance the accuracy of lens fragmentation, improving surgical outcomes. These lasers are also used in LASIK and other refractive surgeries to create corneal flaps with high precision, minimizing tissue damage and promoting faster recovery. Continuous improvements in femtosecond laser technology, such as enhanced imaging systems and software integration, are driving market growth. Due to such factors, the femtosecond lasers segment held the largest segmental market share in 2023.

Further, excimer lasers are extensively used in procedures like LASIK, PRK, and LASEK to reshape the cornea and correct refractive errors such as myopia, hyperopia, and astigmatism. Innovations in excimer laser technology, including wavefront-guided and topography-guided procedures, enhance treatment outcomes and patient satisfaction. Also, Nd: YAG lasers are commonly used for posterior capsulotomy, a procedure to treat clouding of the posterior capsule that can occur after cataract surgery. These lasers are also used for peripheral iridotomy to treat narrow-angle glaucoma. Growing awareness and early diagnosis of glaucoma are contributing to the increased use of Nd: YAG lasers in glaucoma treatment.

Segmentation by Product Type

Femtosecond Lasers
Excimer Lasers
Nd: YAG Lasers
Diode Lasers
Others

INSIGHTS BY APPLICATION

The global ophthalmic lasers market by application is segmented into refractive error, cataract, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and others. The refractive error segment dominates the global market share. Refractive errors, including myopia, hyperopia, astigmatism, and presbyopia, are among the most common vision problems globally. Ophthalmic lasers are crucial in correcting these errors through procedures such as LASIK and PRK. The increasing prevalence of myopia, especially among younger populations, growing awareness of laser vision correction, and advancements in laser technologies support the segment's growth. Also, there is a rising demand for customized LASIK procedures that offer personalized correction based on detailed eye mapping.

Furthermore, glaucoma, characterized by increased intraocular pressure (IOP) leading to optic nerve damage, is a major cause of irreversible blindness. Laser therapies are essential in managing glaucoma by reducing IOP and preventing further vision loss. The high prevalence of glaucoma, increasing awareness of early diagnosis and treatment, and advancements in laser treatment options support the glaucoma segment growth during the forecast period. Also, AMD, a leading cause of vision loss among the elderly, affects the central part of the retina (macula), impairing central vision. Laser treatments manage certain forms of AMD and prevent further vision deterioration. The increasing aging population, rising incidence of AMD, and advancements in laser treatment techniques are driving the AMD market growth.

Segmentation by Application

Refractive Error
Cataract
Glaucoma
Diabetic Retinopathy
Age-related Macular Degeneration (AMD)
Others

INSIGHTS BY END-USER

The global ophthalmic lasers market by end-user is segmented into multispecialty hospitals, standalone eye care centers, and ASCs. The multispecialty hospitals held the most significant segmental market share in 2023. Multispecialty hospitals are comprehensive healthcare facilities that offer a wide range of medical services, including specialized ophthalmology departments. These hospitals are often equipped with state-of-the-art technology and staffed by highly trained professionals, making them key players in the ophthalmic lasers market. Furthermore, ASCs provide efficient, same-day surgical services, reducing hospital stays and associated costs. Procedures performed in ASCs are often less expensive than those in hospitals, making them an attractive option for patients and insurers. ASCs specializing in ophthalmology ensure that staff and facilities are optimized for eye surgeries, enhancing the quality of care.

Segmentation by End-user

Multispecialty Hospitals
Standalone Eye Care Centers
ASCs

GEOGRAPHICAL ANALYSIS

North America dominates the global ophthalmic lasers market share, accounting for a global revenue share of over 40% in 2023. North America, particularly the U.S., holds a significant share of the global ophthalmic lasers market. This is attributed to the high prevalence of eye diseases, advanced healthcare infrastructure, and the strong presence of leading market players. Also, the increased aging population and strong healthcare expenditure support the U.S. market growth. The region also benefits from high patient awareness and adoption of advanced medical technologies. Further, Europe represents a mature market with substantial demand for ophthalmic lasers, driven by advanced healthcare systems and a high prevalence of age-related eye conditions. Robust healthcare infrastructure, significant R&D investments, and favorable reimbursement policies drive the European ophthalmic lasers market. Countries like Germany, France, and the UK are major contributors to the market growth.

Segmentation by Geography

North America
- The U.S.
- Canada
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Russia
- Netherlands
APAC
- China
- Japan
- India
- South Korea
- Australia
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
- UAE

VENDOR LANDSCAPE

The global ophthalmic laser market is highly competitive, characterized by rapid technological advancements, strategic collaborations, and a focus on innovation to address the diverse needs of patients and healthcare providers worldwide. Several factors, including the increasing prevalence of eye disorders such as cataracts, glaucoma, diabetic retinopathy, and AMD, drive the ophthalmic laser market. Technological advancements in laser-based surgical treatments, rising healthcare expenditure, and growing awareness about eye health contribute significantly to market growth. Moreover, the shift towards minimally invasive procedures and the demand for improved patient outcomes further propel industry expansion.

Global initiatives focusing on eye health awareness have significantly heightened patient knowledge about treatment options, including ophthalmic laser procedures. As a result, there is a growing demand for these procedures worldwide, driven by aging populations, lifestyle changes impacting eye health, and increased affordability of healthcare services in emerging markets. The key players in the global ophthalmic lasers market include Alcon, Bausch + Lomb, Johnson & Johnson, NIDEK, and ZEISS. Further, Alcon, a prominent player in the global healthcare sector, particularly in ophthalmology, has established a significant presence in the ophthalmic lasers industry. Alcon's portfolio in the market encompasses various advanced technologies tailored to address various eye conditions. Alcon provides laser systems designed for procedures like LASIK and PRK to correct refractive errors such as myopia, hyperopia, and astigmatism. Their product lineup includes femtosecond lasers used in cataract surgery to improve precision and outcomes, offering advanced features for lens fragmentation and corneal incisions.

Key Company Profiles

Alcon
Bausch + Lomb
Johnson & Johnson
NIDEK
ZEISS

Other Prominent Vendors

Alna-Medicalsystem AG & Co. KG
ARC Laser GmbH
BVI
INTERmedic Arfran
IRIDEX
iVIS Technologies
LENSAR
LIGHTMED
Lumenis Be
Lumibird Medical
MEDA
MERIDIAN AG
Modulight
OD-OS
SCHWIND eye-tech-solutions
Topcon
Ziemer Ophthalmic Systems AG

KEY QUESTIONS ANSWERED:

1. How big is the ophthalmic laser market?

2. What is the growth rate of the global ophthalmic lasers market?

3. What are the significant trends in the ophthalmic lasers industry?

4. Which region dominates the global ophthalmic lasers market share?

Product Code: ARZ240802

1. SCOPE & COVERAGE

1.1. MARKET DEFINITION
- 1.1.1. INCLUSIONS
- 1.1.2. EXCLUSIONS
- 1.1.3. MARKET ESTIMATION CAVEATS
- 1.1.4. MARKET SEGMENTATION
- 1.1.5. MARKET BY PRODUCT TYPE
- 1.1.6. MARKET BY APPLICATION
- 1.1.7. MARKET BY END-USER
- 1.1.8. REGIONS & COUNTRIES COVERED:
1.2. MARKET DERIVATION
- 1.2.1. BASE YEAR

2. PREMIUM INSIGHTS

2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
- 2.2.1. MARKET DYNAMICS
- 2.2.2. GEOGRAPHY INSIGHTS
- 2.2.3. PRODUCT TYPE INSIGHTS
- 2.2.4. APPLICATION INSIGHTS
- 2.2.5. END-USER INSIGHTS

3. MARKET AT A GLANCE

4. INTRODUCTION

4.1. OVERVIEW

5. MARKET OPPORTUNITIES & TRENDS

5.1. EXPANDING OPHTHALMIC LASER APPLICATION IN GLAUCOMA TREATMENT
5.2. ADVANCEMENTS IN LASER TECHNOLOGY FOR OPHTHALMIC SURGERY
5.3. CONTINUOUS PRODUCT APPROVALS
5.4. DESIRE OF INDIVIDUALS TO HAVE PERFECT VISION WITHOUT LENSES & EYEGLASSES

6. MARKET GROWTH ENABLERS

6.1. RISING PREVALENCE OF EYE DISORDERS
6.2. INCREASING ADOPTION OF LASERS IN REFRACTIVE ERROR SURGERY
6.3. GROWING POPULARITY OF FEMTOSECOND LASERS IN OPHTHALMIC SURGERY
6.4. GROWING PREFERENCE FOR MINIMALLY INVASIVE OPHTHALMIC PROCEDURES

7. MARKET RESTRAINTS

7.1. AVAILABILITY OF ALTERNATIVE SOLUTIONS
7.2. HIGH COST OF EQUIPMENT & THERAPY
7.3. DISADVANTAGES OF LASER TECHNOLOGY FOR EYES

8. MARKET LANDSCAPE

8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
- 8.3.1. THREAT OF NEW ENTRANTS
- 8.3.2. BARGAINING POWER OF SUPPLIERS
- 8.3.3. BARGAINING POWER OF BUYERS
- 8.3.4. THREAT OF SUBSTITUTES
- 8.3.5. COMPETITIVE RIVALRY

9. PRODUCT TYPE

9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. FEMTOSECOND LASERS
- 9.3.1. MARKET OVERVIEW
- 9.3.2. MARKET SIZE & FORECAST
- 9.3.3. FEMTOSECOND LASERS MARKET BY GEOGRAPHY
9.4. EXCIMER LASERS
- 9.4.1. MARKET OVERVIEW
- 9.4.2. MARKET SIZE & FORECAST
- 9.4.3. EXCIMER LASERS MARKET BY GEOGRAPHY
9.5. ND: YAG LASERS
- 9.5.1. MARKET OVERVIEW
- 9.5.2. MARKET SIZE & FORECAST
- 9.5.3. ND: YAG MARKET BY GEOGRAPHY
9.6. DIODE LASERS
- 9.6.1. MARKET OVERVIEW
- 9.6.2. MARKET SIZE & FORECAST
- 9.6.3. DIODE LASERS MARKET BY GEOGRAPHY
9.7. OTHERS
- 9.7.1. MARKET OVERVIEW
- 9.7.2. MARKET SIZE & FORECAST
- 9.7.3. OTHERS MARKET BY GEOGRAPHY

10. APPLICATION

10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. REFRACTIVE ERROR
- 10.3.1. MARKET OVERVIEW
- 10.3.2. MARKET SIZE & FORECAST
- 10.3.3. REFRACTIVE ERROR MARKET BY GEOGRAPHY
10.4. CATARACT
- 10.4.1. MARKET OVERVIEW
- 10.4.2. MARKET SIZE & FORECAST
- 10.4.3. CATARACT MARKET BY GEOGRAPHY
10.5. GLAUCOMA
- 10.5.1. MARKET OVERVIEW
- 10.5.2. MARKET SIZE & FORECAST
- 10.5.3. GLAUCOMA MARKET BY GEOGRAPHY
10.6. DIABETIC RETINOPATHY
- 10.6.1. MARKET OVERVIEW
- 10.6.2. MARKET SIZE & FORECAST
- 10.6.3. DIABETIC RETINOPATHY MARKET BY GEOGRAPHY
10.7. AGE-RELATED MACULAR DEGENERATION (AMD)
- 10.7.1. MARKET OVERVIEW
- 10.7.2. MARKET SIZE & FORECAST
- 10.7.3. AMD MARKET BY GEOGRAPHY
10.8. OTHERS
- 10.8.1. MARKET OVERVIEW
- 10.8.2. MARKET SIZE & FORECAST
- 10.8.3. OTHERS MARKET BY GEOGRAPHY

11. END-USER

11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. MULTISPECIALTY HOSPITALS
- 11.3.1. MARKET OVERVIEW
- 11.3.2. MARKET SIZE & FORECAST
- 11.3.3. MULTISPECIALTY HOSPITALS MARKET BY GEOGRAPHY
11.4. STANDALONE EYE CARE CENTERS
- 11.4.1. MARKET OVERVIEW
- 11.4.2. MARKET SIZE & FORECAST
- 11.4.3. STANDALONE EYE CARE CENTERS MARKET BY GEOGRAPHY
11.5. AMBULATORY SURGICAL CENTERS (ASC)
- 11.5.1. MARKET OVERVIEW
- 11.5.2. MARKET SIZE & FORECAST
- 11.5.3. ASCS MARKET BY GEOGRAPHY

12. GEOGRAPHY

12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. GEOGRAPHIC OVERVIEW

13. NORTH AMERICA

13.1. MARKET OVERVIEW
13.2. MARKET SIZE & FORECAST
- 13.2.1. NORTH AMERICA BY PRODUCT TYPE
- 13.2.2. NORTH AMERICA BY APPLICATION
- 13.2.3. NORTH AMERICA BY END-USER
13.3. KEY COUNTRIES
- 13.3.1. US: MARKET SIZE & FORECAST
- 13.3.2. CANADA: MARKET SIZE & FORECAST

14. EUROPE

14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
- 14.2.1. EUROPE BY PRODUCT TYPE
- 14.2.2. EUROPE BY APPLICATION
- 14.2.3. EUROPE BY END-USER
14.3. KEY COUNTRIES
- 14.3.1. GERMANY: MARKET SIZE & FORECAST
- 14.3.2. FRANCE: MARKET SIZE & FORECAST
- 14.3.3. UK: MARKET SIZE & FORECAST
- 14.3.4. ITALY: MARKET SIZE & FORECAST
- 14.3.5. SPAIN: MARKET SIZE & FORECAST
- 14.3.6. RUSSIA: MARKET SIZE & FORECAST
- 14.3.7. NETHERLANDS: MARKET SIZE & FORECAST

15. APAC

15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
- 15.2.1. APAC BY PRODUCT TYPE
- 15.2.2. APAC BY APPLICATION
- 15.2.3. APAC BY END-USER
15.3. KEY COUNTRIES
- 15.3.1. CHINA: MARKET SIZE & FORECAST
- 15.3.2. JAPAN: MARKET SIZE & FORECAST
- 15.3.3. INDIA: MARKET SIZE & FORECAST
- 15.3.4. SOUTH KOREA: MARKET SIZE & FORECAST
- 15.3.5. AUSTRALIA: MARKET SIZE & FORECAST

16. LATIN AMERICA

16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
- 16.2.1. LATIN AMERICA BY PRODUCT TYPE
- 16.2.2. LATIN AMERICA BY APPLICATION
- 16.2.3. LATIN AMERICA BY END-USER
16.3. KEY COUNTRIES
- 16.3.1. BRAZIL: MARKET SIZE & FORECAST
- 16.3.2. MEXICO: MARKET SIZE & FORECAST
- 16.3.3. ARGENTINA: MARKET SIZE & FORECAST
- 16.3.4. COLOMBIA: MARKET SIZE & FORECAST

17. MIDDLE EAST & AFRICA

17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
- 17.2.1. MEA BY PRODUCT TYPE
- 17.2.2. MEA BY APPLICATION
- 17.2.3. MEA BY END-USER
17.3. KEY COUNTRIES
- 17.3.1. TURKEY: MARKET SIZE & FORECAST
- 17.3.2. SOUTH AFRICA: MARKET SIZE & FORECAST
- 17.3.3. SAUDI ARABIA: MARKET SIZE & FORECAST
- 17.3.4. UAE: MARKET SIZE & FORECAST

18. COMPETITIVE LANDSCAPE

18.1. COMPETITION OVERVIEW
18.2. MARKET SHARE ANALYSIS
- 18.2.1. ALCON
- 18.2.2. BAUSCH + LOMB
- 18.2.3. JOHNSON & JOHNSON
- 18.2.4. NIDEK
- 18.2.5. ZEISS

19. KEY COMPANY PROFILES

19.1. ALCON
- 19.1.1. BUSINESS OVERVIEW
- 19.1.2. PRODUCT OFFERINGS
- 19.1.3. KEY STRATEGIES
- 19.1.4. KEY STRENGTHS
- 19.1.5. KEY OPPORTUNITIES
19.2. BAUSCH + LOMB
- 19.2.1. BUSINESS OVERVIEW
- 19.2.2. PRODUCT OFFERINGS
- 19.2.3. KEY STRATEGIES
- 19.2.4. KEY STRENGTHS
- 19.2.5. KEY OPPORTUNITIES
19.3. JOHNSON & JOHNSON
- 19.3.1. BUSINESS OVERVIEW
- 19.3.2. PRODUCT OFFERINGS
- 19.3.3. KEY STRATEGIES
- 19.3.4. KEY STRENGTHS
- 19.3.5. KEY OPPORTUNITIES
19.4. NIDEK
- 19.4.1. BUSINESS OVERVIEW
- 19.4.2. PRODUCT OFFERINGS
- 19.4.3. KEY STRATEGIES
- 19.4.4. KEY STRENGTHS
- 19.4.5. KEY OPPORTUNITIES
19.5. ZEISS
- 19.5.1. BUSINESS OVERVIEW
- 19.5.2. PRODUCT OFFERINGS
- 19.5.3. KEY STRATEGIES
- 19.5.4. KEY STRENGTHS
- 19.5.5. KEY OPPORTUNITIES

20. OTHER PROMINENT VENDORS

20.1. ALNA-MEDICALSYSTEM AG & CO. KG
- 20.1.1. BUSINESS OVERVIEW
- 20.1.2. PRODUCT OFFERINGS
20.2. ARC LASER GMBH
- 20.2.1. BUSINESS OVERVIEW
- 20.2.2. PRODUCT OFFERINGS
20.3. BVI
- 20.3.1. BUSINESS OVERVIEW
- 20.3.2. PRODUCT OFFERINGS
20.4. INTERMEDIC ARFRAN
- 20.4.1. BUSINESS OVERVIEW
- 20.4.2. PRODUCT OFFERINGS
20.5. IRIDEX
- 20.5.1. BUSINESS OVERVIEW
- 20.5.2. PRODUCT OFFERINGS
20.6. IVIS TECHNOLOGIES
- 20.6.1. BUSINESS OVERVIEW
- 20.6.2. PRODUCT OFFERINGS
20.7. LENSAR
- 20.7.1. BUSINESS OVERVIEW
- 20.7.2. PRODUCT OFFERINGS
20.8. LIGHTMED
- 20.8.1. BUSINESS OVERVIEW
- 20.8.2. PRODUCT OFFERINGS
20.9. LUMENIS BE
- 20.9.1. BUSINESS OVERVIEW
- 20.9.2. PRODUCT OFFERINGS
20.10. LUMIBIRD MEDICAL
- 20.10.1. BUSINESS OVERVIEW
- 20.10.2. PRODUCT OFFERINGS
20.11. MEDA
- 20.11.1. BUSINESS OVERVIEW
- 20.11.2. PRODUCT OFFERINGS
20.12. MERIDIAN AG
- 20.12.1. BUSINESS OVERVIEW
- 20.12.2. PRODUCT OFFERINGS
20.13. MODULIGHT
- 20.13.1. BUSINESS OVERVIEW
- 20.13.2. PRODUCT OFFERINGS
20.14. OD-OS
- 20.14.1. BUSINESS OVERVIEW
- 20.14.2. PRODUCT OFFERINGS
20.15. SCHWIND EYE-TECH-SOLUTIONS
- 20.15.1. BUSINESS OVERVIEW
- 20.15.2. PRODUCT OFFERINGS
20.16. TOPCON
- 20.16.1. BUSINESS OVERVIEW
- 20.16.2. PRODUCT OFFERINGS
20.17. ZIEMER OPHTHALMIC SYSTEMS AG
- 20.17.1. BUSINESS OVERVIEW
- 20.17.2. PRODUCT OFFERINGS

21. REPORT SUMMARY

21.1. KEY TAKEAWAYS
21.2. STRATEGIC RECOMMENDATIONS

22. QUANTITATIVE SUMMARY

22.1. MARKET BY PRODUCT TYPE
- 22.1.1. NORTH AMERICA BY PRODUCT TYPE
- 22.1.2. EUROPE BY PRODUCT TYPE
- 22.1.3. APAC BY PRODUCT TYPE
- 22.1.4. LATIN AMERICA BY PRODUCT TYPE
- 22.1.5. MEA BY PRODUCT TYPE
22.2. MARKET BY APPLICATION
- 22.2.1. NORTH AMERICA BY APPLICATION
- 22.2.2. EUROPE BY APPLICATION
- 22.2.3. APAC BY APPLICATION
- 22.2.4. LATIN AMERICA BY APPLICATION
- 22.2.5. MEA BY APPLICATION
22.3. MARKET BY END-USER
- 22.3.1. NORTH AMERICA BY END-USER
- 22.3.2. EUROPE BY END-USER
- 22.3.3. APAC BY END-USER
- 22.3.4. LATIN AMERICA BY END-USER
- 22.3.5. MEA BY END-USER
22.4. MARKET BY GEOGRAPHY
- 22.4.1. FEMTOSECOND LASERS MARKET BY GEOGRAPHY
- 22.4.2. EXCIMER LASERS MARKET BY GEOGRAPHY
- 22.4.3. ND: YAG MARKET BY GEOGRAPHY
- 22.4.4. DIODE LASERS MARKET BY GEOGRAPHY
- 22.4.5. OTHERS MARKET BY GEOGRAPHY
- 22.4.6. REFRACTIVE ERROR MARKET BY GEOGRAPHY
- 22.4.7. CATARACT MARKET BY GEOGRAPHY
- 22.4.8. GLAUCOMA MARKET BY GEOGRAPHY
- 22.4.9. DIABETIC RETINOPATHY MARKET BY GEOGRAPHY
- 22.4.10. AMD MARKET BY GEOGRAPHY
- 22.4.11. OTHER APPLICATIONS MARKET BY GEOGRAPHY
- 22.4.12. MULTISPECIALTY HOSPITALS MARKET BY GEOGRAPHY
- 22.4.13. STANDALONE EYE CARE CENTERS MARKET BY GEOGRAPHY
- 22.4.14. ASCS MARKET BY GEOGRAPHY

23. APPENDIX

23.1. RESEARCH METHODOLOGY
23.2. RESEARCH PROCESS
23.3. REPORT ASSUMPTIONS & CAVEATS
- 23.3.1. KEY CAVEATS
- 23.3.2. CURRENCY CONVERSION
23.4. ABBREVIATIONS